MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

AAN

Interview: Dr Rebecca Spain – AAN Meeting 2016

MStranslate
April 21, 2016
AAN, Conferences, Research, Treatments
1 Comment
AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR REBECCA SPAIN – OREGON HEALTH AND SCIENCES UNIVERSITY (OHSU), VA PORTLAND HEALTH CARE SYSTEM BD: Brett Drummond,...
AAN

Interview: Dr Tomas Kalincik – AAN Meeting 2016

MStranslate
April 19, 2016
AAN, Conferences, Research
AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR TOMAS KALINCIK – MELBOURNE BRAIN CENTRE, ROYAL MELBOURNE HOSPITAL BD: Brett Drummond, MStranslate TK: Dr Tomas Kalincik,...
Antihistamine

Antihistamine may stimulate myelin repair

MStranslate
April 13, 2016
Clinical Trials, Remyelination, Research, Treatments
1 Comment
A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially reverse damage to the optic nerve in people with multiple...
stem cell

Stem Cell Culture Media Improves EAE

MStranslate
April 11, 2016
Research, Stem Cells, Treatments
Research Summary: Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis The background Current MS therapies mostly work to suppress...
microbiome

Gut Microbiome Alters Myelination

MStranslate
April 6, 2016
Research, Treatments
Research Summary: Regulation of prefrontal cortex myelination by the microbiota The Background In recent times, there has been an increasing focus placed on the role that the gut microbiome (composed of...
Rituximab

Rituximab vs Fingolimod in JCV+ Individuals

MStranslate
April 5, 2016
Fingolimod, Natalizumab, Research, Rituximab
Research Summary: Rituximab versus fingolimod after natalizumab in multiple sclerosis patients The background Whilst natalizumab has emerged as a potent treatment for multiple sclerosis (MS), it is also...
Research

Rehearse then Research – By Brett Drummond

MStranslate
April 1, 2016
Opinion, Research
An MStranslate Opinion Piece When I was younger, I was cast in the role of Robin Hood in a school musical.  I robbed from the rich to give to the poor.  My delusions of becoming acting royalty resulted in...
Plant peptides

Can Plant Peptides Treat Multiple Sclerosis?

MStranslate
March 31, 2016
Research
Research Summary: Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis The background When developing new therapies, an ideal outcome is that they will be able to be...
Natalizumab

Natalizumab, B cells and Multiple Sclerosis

MStranslate
March 29, 2016
B Cells, Basic Sciences, Natalizumab, Research, Treatments
Research Summary: Cutting Edge: Integrin a4 is required for regulatory B cell control of experimental autoimmune encephalomyelitis The background For a long time, multiple sclerosis was regarded as an...

Effects of Exercise on BDNF Protein Levels in MS

MStranslate
March 21, 2016
Lifestyle, Research
Research Summary: Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training The background Brain derived neurotrophic factor (BDNF) is a protein that...
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25
  6. 26
  7. 27

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.